Related Experiment Video
Updated: Apr 5, 2026
08:15
Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
Published on: August 15, 2025
1.3K
[Metformin-associated lactic acidosis].
Summary
Metformin-associated lactic acidosis is a serious risk in type II diabetes patients, especially those with reduced kidney function. Strict adherence to prescription and patient education are crucial to prevent this potentially fatal complication.
Area of Science:
- Nephrology
- Endocrinology
- Pharmacology
Background:
- Metformin is a primary treatment for type II diabetes.
- Renal excretion of metformin necessitates caution with reduced glomerular filtration rates.
- Metformin accumulation can lead to lactic acidosis, a high-mortality complication.
Purpose of the Study:
- To investigate the incidence, risk factors, and outcomes of metformin-associated lactic acidosis.
- To evaluate patient characteristics and management strategies for this complication.
Main Methods:
- Retrospective review of 390,000 patients over 15 months.
- Analysis of metformin-associated lactic acidosis cases treated at a First Aid unit.
- Inclusion of patient characteristics, risk factors, and outcomes.
Main Results:
- Observed 11 cases of metformin-associated lactic acidosis (incidence 60/year/100,000 patients).
- 10 cases involved acute renal failure due to dehydration; most patients had risk factors for acute kidney injury.
- 36% total mortality rate, with 10 patients requiring hemodialysis.
Conclusions:
- Higher incidence observed, likely due to metformin use in increasingly fragile patients.
- Emphasized strict adherence to prescription, monitoring renal function, and identifying risk factors (age >80, ACE inhibitors, ARBs, diuretics).
- Highlighted the importance of managing acute events and educating patients/relatives.
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
962
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
962
01:23Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
887
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
887
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
01:06Oral Hypoglycemic Agents: Glinides
961
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
961
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K